Clinical Trials Reporting Program (CTRP) and Clinicaltrials.gov (CT.gov) Helpful tips and guidance
|
|
- Peter Stephens
- 8 years ago
- Views:
Transcription
1 Clinical Trials Reporting Program (CTRP) and Clinicaltrials.gov (CT.gov) Helpful tips and guidance
2 Objectives
3 NCI s Clinical Trials Reporting Program (CTRP) Overview
4 CTRP What is it? CTRP is an NCI mandated comprehensive protocol registration database of regularly updated information on all NCI-supported clinical trials. The database was created due to the initiative of the Clinical Trials Working Group (CTWG) Report It was created to help identify gaps and duplicative studies in clinical research and to facilitate prioritization of clinical trials for the NCI Any NCI-supported interventional trials opened to accrual as of or after January 1, 2009 requires registration Cancer Centers were able to apply for supplemental funding to help fund a CTRP Coordinator position
5 CTRP What is it? NCI-supported means all trials sponsored or otherwise financially supported by the NCI. This means that all interventional clinical trials conducted at NCI-designated Cancer Centers must be registered no matter who the sponsor is including Investigator- Initiated and industry sponsored trials Exceptions to this rule are studies that are reviewed and monitored by NCI CTEP, DCP PIOs, and NCI CCR. These trials are not required to be registered via the CTRP registration site by the designated Cancer Centers
6 What does this mean for the UWCCC? For our purposes, all interventional trials (therapeutic, supportive care, and prevention) as well as Screening, Detection, and Early Diagnostic studies that are considered IITs will be required to be registered via CTRP Who is responsible for the registration? Your UWCCC CTRP Coordinator!
7 What does the CTRP Coordinator do? The CTRP Coordinator performs the initial registration of required trials into the CTRP Registration database The coordinator is also responsible for all updates to trials once registered including submission of major amendments, status updates, participating site information, and accrual
8 What information is required for registration into CTRP? Minimum information required for registration: Protocol Number Protocol Title Trial Type Phase Current Trial Status and Date this includes anticipated completion dates Lead Organization PI NIH Grant information if applicable Responsible Party Regulatory Information See CT.GOV/CTRP tab in the Main Tab of the PC Console in OnCore Trial Related Documents Protocol Participating Site List IRB Approval Document OR Memo of Pending IRB Approval when registration occurs pre-approval
9 What happens when a study is registered? Once a study has been registered, the NCI CTRO staff extracts the information from the protocol and registration page and plugs it into a Trial Summary Report (TSR) The TSR is sent to the CTRP Coordinator for review to ensure accuracy Once reviewed, the coordinator accepts the TSR (or submits revisions) and the study is considered registered in CTRP
10 What exactly is a Trial Summary Report (TSR)? A summary of the information found in the protocol This summary is equivalent to the information that has to be uploaded into ClinicalTrials.gov (CT.gov) As we ll discuss later, the TSR is what allows the CTRP coordinator to upload the CT.gov submissions at the click of a button. A few minor tweaks are done to the record in CT.gov to ensure that the sponsor and organization information are listed correctly. This is why it is important that the groups fill in the required information in the CT.gov/CTRP tab and the Study Completion Dates in OnCore which will also be discussed later in the presentation
11 National Institutes of Health (NIH) ClinicalTrials.gov (CT.gov) Overview
12 CT.gov What is it? CT.gov, originally developed in 2000, is a mandated public access protocol registration database originally developed by the NIH in collaboration with the Food and Drug Administration (FDA) The FDA Amendment Act (FDAAA) added additional requirements for CT.gov including results reporting in September 2007
13 CT.gov What is it? The Food and Drug Administration (FDA) requires study registration (along with results and adverse event reporting) for Phase II - IV interventional drug, biologic or device trials ("applicable clinical trials")
14 What is an applicable clinical trial? Trials of drugs and biologics that are subject to FDA regulation Trials of devices which provide health outcomes subject to FDA regulation and which require pediatric postmarket surveillance This generally includes interventional studies of FDA regulated drugs, biologics, or devices that meet one of the following: Trial has one or more sites in US Trial is conducted under an FDA IND or IDE Trial involves a drug, biologic, or device manufactured in the US and is exported for research
15 What types of trials are excluded? Per FDAAA 801 the following are excluded: Phase I* drug trials Trials where the primary outcome measures feasibility and not health outcomes Trials not including drugs, biologics, or devices Non-interventional trials such as cohort or casecontrol studies Trials ongoing as of 9/27/2007 but reached completion before 12/26/2007 *Please note it is best practice, regardless of phase to register all interventional trials per the ICMJE requirements which will be discussed
16 Who requires registration? FDA - within 20 days of first patient accrued ICMJE - before 1 st patient accrued Center for Medicare & Medicaid Services (CMS) requires the registration of most studies billing third parties for study related services- UW Health Research Billing Compliance Program requires an NCT # (CT.gov registration number) before trial can be approved
17 International Committee of Medical Journal Editors (ICMJE) ICMJE recommends that all medical journal editors require registration of clinical trials in a public registry Trials must be registered at or before the time of the first patient enrollment for consideration of publication ICMJE defines a clinical trial as any research project that prospectively assigns people/groups of people to an intervention to study the relationship between a health intervention and health outcome Much bigger scope than CT.gov for registration
18 What does ICMJE have to do with UWCCC? Some trials that are considered interventional IITs by our standards may not necessarily be required per FDAAA guidelines to be registered to CT.gov however for publishing purposes they must be registered This means it is best to err on the side of caution and register the trial as stated on the ICMJE website Those who are uncertain whether their trial meets the expanded ICMJE definition should err on the side of registration if they wish to seek publication in an ICMJE journal
19 Why comply with Registration? Failing to register or report results for "applicable clinical trials" in a timely manner can result in significant monetary penalties imposed by the FDA Failure to register ( before the first patient accrued) may result in a rejection of a publication by ICMJE
20 CT.gov Results Reporting
21 What about Results Reporting? Per the FDAAA 801 requirements, the Responsible Parties must submit scientific and administrative information about trial results into CT.gov within a year of study completion Submitting results is similar to preparing a manuscript for publication Individuals familiar with the study design and data analysis (such and the PI or statistician) must be involved in order to accurately summarize the information
22 Results Reporting: Brief Overview Scientific information is submitted as four separate modules: Participant Flow Baseline Characteristics Outcome Measures & Statistical Analyses Adverse Events These modules display information in a series of data tables
23 Results Reporting Participant Flow A table...,including the number of patients who dropped out of the clinical trial and the number of patients excluded from the analysis, if any. The module should account for all enrolled participants, and should inform the interpretation of study outcomes by interpretation of study outcomes by illustrating which participants were analyzed
24 Results Reporting Baseline Characteristics A table of the demographic and baseline data collected overall and for each arm of the clinical trial Number of participants Age Gender Race Ethnicity Region of enrollment Entered for each Arm
25 Results Reporting Outcome Measures & Statistical Analyses a table of values for each of the primary and secondary outcome measures for each arm of the clinical trial including the results of scientifically appropriate tests of the statistical significance of such outcome measures.
26 Results Reporting Adverse Events A table of anticipated and unanticipated serious adverse events grouped by organ system, with number and frequency of such event in each arm of the clinical trial.
27 Results Reporting: Miscellaneous Many helpful templates for results reporting can be found at Results reporting MUST be done by the research staff who have worked closely with the protocol the investigator and the statistician MUST be involved in the process it is the investigator s responsibility
28 Bringing it all together
29 What happens after registration to CT.gov? Once the study has been accepted, the CTRP coordinator enters the NCT number into OnCore and tells the DOWG the trial has been registered. Trial ownership is transferred back to the DOWG in order to allow the group to be able to make the timely updates and amendments as required Why back to the DOWG? Amendment information, status changes, etc. must be entered manually, therefore someone who has intimate knowledge of the protocol requiring updates must be the one responsible to ensure key points are updated appropriately
30 Why tie CTRP and CT.gov together? Both databases require registration of interventional trials and utilize similar information CTRP talks to CT.gov this is how we are able to centralize protocol registration for the Cancer Center into CT.gov By utilizing the CTRP registration process, the steps for registering trials to CT.gov became much less complicated and can be handled by a central person instead of each DOWG having to manually register trials
31 What does this mean for the UWCCC? Centralizing CT.gov registration frees up time for the DOWGs and PIs It falls into the workflow that coincides with CTRP registration Central registration helps to meet the new Center for Medicare & Medicaid (CMS) requirements having the NCT number in OnCore before IRB Approval
32 How will this impact workflows? DOWGs may need to change workflows to enter the following fields in OnCore by PRMC Approval for studies requiring CT.gov registration: Enter the Completion Dates in PC Console Main Details Tab under Completion Dates. Follow the OnCore DFDs for instructions. Fill out the CT.Gov/CTRP Tab in PC Console Main CT.GOV/CTRP. Follow the OnCore DFDs for instructions. DOWGs must also contact the CTRP Coordinator via once a qualifying trial has been PRMC approved and attach the protocol to the . This is a back-up verification to ensure that no qualifying protocols would miss a deadline for registration
33 How are trials registered in CT.gov via CTRP? The CTRP Coordinator registers trials with CTRP at PRMC approval pending IRB approval. NCI CTRO Staff extract information from the protocol to provide the TSR The coordinator reviews the TSR and either approves the TSR or submits changes Once the TSR has been approved the trial can be automatically uploaded to CT.gov via CTRP
34
35 CTRP and CT.gov - What does the future hold? Although it may seem like the work can be duplicative both registries were created for different reasons and are managed by separate entities CTRP is working towards working with cancer centers to simplify Summary 4 reporting
36 QUESTIONS?
Basic Results Database
Basic Results Database Deborah A. Zarin, M.D. ClinicalTrials.gov December 2008 1 ClinicalTrials.gov Overview and PL 110-85 Requirements Module 1 2 Levels of Transparency Prospective Clinical Trials Registry
More informationGuidance for Sponsors, Investigators, and Institutional Review Boards. Questions and Answers on Informed Consent Elements, 21 CFR 50.
Guidance for Sponsors, Investigators, and Institutional Review Boards Questions and Answers on Informed Consent Elements, 21 CFR 50.25(c) (Small Entity Compliance Guide) U.S. Department of Health and Human
More informationComparison of Clinical Trials Registry Legislation in the Senate and House Prepared by Tannaz Rasouli, AAMC Office of Governmental Relations
Comparison of Clinical Trials Registry Legislation in the Senate and House Prepared by Tannaz Rasouli, AAMC Office of Governmental Relations Clinical Trials Registry S. 1082 (Title II, Subtitle C) H.R.
More informationInstructions of ClinicalTrials.gov Protocol Registration
Instructions of ClinicalTrials.gov Protocol Registration STEP I: Getting Started 1. Create an account: contact RU ClinicalTrials.gov Protocol Registration System (PRS) Administrator Rebecca Chen (973-972.1149
More informationPrincipal Investigator Responsibilities for Education and Social/Behavioral Researchers
Principal Investigator Responsibilities for Education and Social/Behavioral Researchers Introduction The purpose of this module is to provide a basic understanding of the responsibilities of the principal
More informationSingapore Clinical Trials Register. Foo Yang Tong Director Clinical Trials Branch Health Products Regulation Group HEALTH SCIENCES AUTHORITY
Singapore Clinical Trials Register Foo Yang Tong Director Clinical Trials Branch Health Products Regulation Group HEALTH SCIENCES AUTHORITY Clinical Trial Register Global Trend EMA: EU Clinical Trials
More informationCoverage Analysis: The Cornerstone of Clinical Research Billing Presented by: Mary L. Veazie, CPA, MBA, CHC, CHRC Executive Director, Clinical
Coverage Analysis: The Cornerstone of Clinical Research Billing Presented by: Mary L. Veazie, CPA, MBA, CHC, CHRC Executive Director, Clinical Research Finance The University of Texas MD Anderson Cancer
More informationYale Cancer Center Data and Safety Monitoring Committee Charter
Yale Cancer Center Data and Safety Monitoring Committee Charter Purpose/Mission The purpose of the Yale Cancer Center (YCC) Data and Safety Monitoring Committee (DSMC) is to provide ongoing data and safety
More informationFACT SHEET (Available at http://prsinfo.clinicaltrials.gov/) Registration at ClinicalTrials.gov: As required by Public Law 110-85, Title VIII
10/27/09 NOTE: Section 2, Timing of Registration at ClinicalTrials.gov, was revised on 10/23/09. This document supersedes the Fact Sheet issued on 11/09/07. Note that the new text is highlighted below.
More informationSubject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure
703 1 of 11 POLICY The Beaumont Research Coordinating Center (BRCC) will provide advice to clinical trial investigators on protocol development, content and format. Upon request, the BRCC will review a
More informationAACI NCI CLINICAL TRIALS REPORTING PROGRAM (CTRP) STRATEGIC SUBCOMMITTEE REPORT. CTRP Reporting Objectives and Implementation Timeline
AACI NCI CLINICAL TRIALS REPRTING PRGRA (CTRP) STRATEGIC SUBCITTEE REPRT CTRP Reporting bjectives and Implementation Timeline July 2011 Table of Contents I. EXECUTIVE SUARY 2 II. INTRDUCTIN a. Background
More informationU.S. Food and Drug Administration
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA s website for reference purposes only. It was current when produced, but is no longer maintained
More informationMedical Billing Human Research Studies Seminar Notes
Audits If a department learns that an external audit is going to be initiated, the Billing Compliance Department and Research Administration should be notified when the scope of the audit involves billing
More informationROLE OF THE RESEARCH COORDINATOR Study Start-up Best Practices
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Study Start-up
More informationOnCore Clinical Trial Management System (CTMS) Minimum Standardized Requirements: School of Dentistry
OnCore Clinical Trial Management System (CTMS) Minimum Standardized Requirements: School of Dentistry OnCore CTMS Registration Requirements Main Tab Institution Tab Reviews Tab Status Tab Accrual Tab Version
More informationCENTERS FOR MEDICARE & MEDICAID SERVICES. Medicare & Clinical Research Studies
CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare & Clinical Research Studies You may have the choice to join a clinical research study to diagnose or treat an illness. If you join a covered clinical research
More informationClassifying Adverse Events From Clinical Trials
Classifying Adverse Events From Clinical Trials Bernard LaSalle, Richard Bradshaw University of Utah, Biomedical Informatics, Salt Lake City, UT USA bernie.lasalle@hsc.utah.edu Abstract The use of adverse
More informationJeri & Noboru Oishi Symposium
Jeri & Noboru Oishi Symposium Using the NCI CIRB SWOG Fall Group Meeting Jeanne Hyatt M. Adler, Regency RN, in Chicago MPH, CCRP October 7-10, 2015 CTEP/DCTD/NCI9, 2013 AND LaTisa Hernandez, PA, CCRC,
More informationClinical Trial Protocol Development. Developed by Center for Cancer Research, National Cancer Institute Endorsed by the CTN SIG Leadership Group
Clinical Trial Protocol Development Developed by Center for Cancer Research, National Cancer Institute Endorsed by the CTN SIG Leadership Group Objectives The clinical trial protocol is the heart of any
More informationCLINICAL RESEARCH ROLES CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES
CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES 1. Clinical Study Team Principal Investigator Co Principal Investigator (Co PI) Research Coordinator Study Monitor Data manage Sponsor Post Doctoral Scholar
More informationEffective Date: October 2015
University of Maryland Greenebaum Cancer Center UMGCC Standard Operating Procedure Title: Data & Safety Monitoring Plan Effective Date: October 2015 Procedure No: DSM001 University of Maryland Greenebaum
More informationSTAGE 2 of the EHR Incentive Programs
EHR Incentive Programs A program administered by the Centers for Medicare & Medicaid Services (CMS) Eligible Professional s Guide to STAGE 2 of the EHR Incentive Programs September 2013 TABLE OF CONTENTS...
More informationAURA Clinical Trial FP Guidelines
AURA Clinical Trial FP Guidelines Table of Contents Overview 2 What is a Clinical Trial? Guidelines Acronym/ Abbreviations/ Key Codes FP Workflow.. Step 1: PC-O create CT.. 3 Step 2: OCR/ URA-M advance
More informationResearch Coordinator - PI s who have research coordinators or secretarial support can designate individuals to manage their IRB protocols in Mentor.
Mentor Online IRB System IRB s require lots of documentation and managing this process can get to be a burden for both investigators and the IRB committee and administrator. The Mentor IRB system is designed
More informationChildren s Research Management System (CRMS) Version 3.0. Children s Hospital Colorado Research Institute Training Guide April 2015
Children s Research Management System (CRMS) Version 3.0 Children s Hospital Colorado Research Institute Training Guide April 2015 Table of Contents Operational Needs Assessment (ONA) 3 Visit Schedules
More informationHow to Create a New Clinical Research Study
How to Create a New Clinical Research Study 1 Contents 1. Create a Submission for an Existing eirb Study... 3 2. Create a New Submission in eirb... 4 3. CRMS Clinical Research Study... 5 4. Uploading a
More information2. For all clinical trials, the coverage analysis will also be audited to ensure compliance with the Medicare National Coverage Determination.
COMPLIANCE PROGRAM POLICY: Clinical Research Billing Audit Policy Effective Date: August 1, 2014 Last Updated: Page 1 of 8 I. POLICY All UC Irvine Health departments engaged in clinical research may be
More informationMedicare Billing. Lisa R. Pitler, JD, MS, RN Assistant Vice Chancellor Research, Director of Clinical Trials Office University of Illinois at Chicago
Medicare Billing Lisa R. Pitler, JD, MS, RN Assistant Vice Chancellor Research, Director of Clinical Trials Office University of Illinois at Chicago May 14, 2015 Presentation Objectives Understand and
More information2013 Meaningful Use Dashboard Calculation Guide
2013 Meaningful Use Dashboard Calculation Guide Learn how to use Practice Fusion s Meaningful Use Dashboard to help you achieve Meaningful Use. For more information, visit the Meaningful Use Center. General
More informationCTEP Workshop. An Overview of the NCI s Cancer Therapy and Evaluation Program (CTEP) CTEP s Mission. Workshop Objectives. NCI Organizational Structure
CTEP Workshop Elizabeth Ness, RN, MS Director, Staff Development Center for Cancer Research National Cancer Institute Workshop Objectives At the end of this workshop, participants will be able to: Discuss
More informationCTSU Operational ET-CTN. April 21, 2013
CTSU Operational Support Services for the ET-CTN Early Drug Development tmeeting April 21, 2013 1 Presentation Agenda Describe the Objectives of Consolidating ET- CTN Support Services Provide an Overview
More informationCore Training Outline
Core Training Outline Modules: 1) Study Design 2) PI Oversight 3) Financial Management 4) Study Operations 5) Recruitment & Retention 6) Informed Consent 7) Investigational Products 8) Subject Safety 9)
More informationDHHS/NIH/OD/OIR/OHSRP 1/2/2015
DHHS/NIH/OD/OIR/OHSRP 1/2/2015 The audience for this course is Principal Investigators (PIs), investigators and Research Coordinators (RCs) serving on the study team of human clinical studies and trials.
More informationProposal Development Guide
Proposal Development Guide Contents The Proposal Tab... 3 Document Overview Panel... 3 Required Fields for Saving Document Panel... 3 Institutional Fields (Conditionally Required)... 9 Sponsor & Program
More informationGuidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions
Guidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions U.S. Department of Health and Human Services Food and Drug Administration Center for
More informationSTANDARD OPERATING PROCEDURE FORMAL COVERAGE ANALYSIS
PURPOSE Establish a consistent comprehensive coverage analysis process that is well defined and performed on every clinical trial. UCSF REQUIREMENT Effective 6/1/2013, a formal coverage analysis must be
More informationThe Beginner Research Assistant/Coordinator (CRC) Track Basic Level
The Beginner Research Assistant/Coordinator (CRC) Track Basic Level Who: Clinical Research Assistant (CRA) CRC I This track was designed for the CRA/CRC I with less than 2 years of clinical research experience.
More informationThe Ontario Cancer Research Ethics Board Overview
The Ontario Cancer Research Ethics Board Overview Research Ethics Research ethics review is vital to the advancement of ethically sound research. Before individuals can be enrolled in a research study,
More informationUNIVERSITY OF CALIFORNIA, SAN DIEGO HUMAN RESEARCH PROTECTIONS PROGRAM. DoD/DON-funded Research
UNIVERSITY OF CALIFORNIA, SAN DIEGO HUMAN RESEARCH PROTECTIONS PROGRAM DoD/DON-funded Research Policy In 2006, the Department of the Navy (DON) enhanced its human subject protection requirements, including
More informationClinical Trial Transparency. What is available?
Clinical Trial Transparency What is available? 1 Outline Clinical Trial Data Collection and Reporting Data Definitions Clinical Trial Transparency Summary Report Requirements Example of Results Posting
More informationJoint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009
Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009 The innovative pharmaceutical industry 2 is committed to the transparency
More informationOnCore Clinical Research Management System Standard Operating Procedures
Purpose: This standard operating procedure (SOP) provide definitions for terms used in the OnCore clinical research management system at Georgia Regents University (GRU). 2.0 Scope: Applies to all site
More informationClinical Research Management Webinar Series: Results of Huron s Clinical Trials Management System Survey
Clinical Research Management Webinar Series: Results of Huron s Clinical Trials Management System Survey Wednesday, October 24, 2012 12:00 p.m. - 1:00 p.m. CT About our speakers Rick Rohrbach Managing
More informationOffice of Research Administration: Clinical Research Contracting
Office of Research Administration: Clinical Research Contracting Presented to: Research Administration Professionals Group Presented by: Patricia Travis and Mont Brownlee October 22, 2013 1 Training Agenda
More informationFebruary 2006 Procedural
Guidance for Industry Reports on the Status of Postmarketing Study Commitments Implementation of Section 130 of the Food and Drug Administration Modernization Act of 1997 U.S. Department of Health and
More informationClinical Trials: Questions and Answers
Clinical Trials: Questions and Answers Key Points Clinical trials are research studies that test how well new medical approaches work in people (see Question 1). Every clinical trial has a protocol, which
More informationHuman Research Protection Program Good Clinical Practice Guidance for Investigators Investigator & Research Staff Responsibilities
This Guidance Document is to ensure that investigators and research personnel recognize their responsibilities associated with the conduct of human subject research by outlining their responsibilities,
More informationPre-Questions. Mastering Clinical Research July 29, 2015
Pre-Questions Mastering Clinical Research July 29, 2015 1. To be compliant with SOP 2.1 Obtaining Informed Consent for greater than minimal risk interventional clinical trial, which Licensed Professional
More informationHow To Write A Binder Tab
Tool Summary Sheet Tool: Extramural Essential Documents Binder/File Tabs Purpose: To provide an organizational framework and guidance for filing paper versions of essential study documents (or referencing
More informationCOMET Clinical Trials Consortium
COMET Clinical Trials Consortium User Manual www.comettrials.com CCTC Founder Christine Brezden-Masley, MD PhD FRCPC Medical Oncologist, St. Michael s Hospital Assistant Professor, University of Toronto
More informationIs it time for a new drug development paradigm?
Is it time for a new drug development paradigm? Robert McDonough, M.D. Senior Director, Clinical Policy Research and Development 1 The Aetna Way Our Cause To make quality health care more affordable and
More informationWhat s Next for Data Sharing: Insight from the NIH Experience
What s Next for Data Sharing: Insight from the NIH Experience Jerry Sheehan Assistant Director for Policy Development National Library of Medicine National Institutes of Health SHARE In-Person Meeting
More informationGuidance on IRB Continuing Review of Research
NOTE: THIS GUIDANCE SUPERSEDES OHRP S JANUARY 15, 2007 GUIDANCE ENTITILED GUIDANCE ON CONTINUING REVIEW. CLICK HERE FOR THE JANUARY 15, 2007 GUIDANCE. Office for Human Research Protections Department of
More informationEarly Phase Clinical Trials: Public Access to the EU Database Repository
European CRO Federation Via Lucrezio Caro, 63 00193 Roma, Italy Tel.: +39 06 807 60 72 Fax: +39 06 807 60 85 Email: info@eucrof.eu Internet: www.eucrof.eu Early Phase Clinical Trials: Public Access to
More informationMandatory Reporting of National Clinical Trial (NCT) Identifier Numbers on Medicare Claims Qs & As
Mandatory Reporting of National Clinical Trial (NCT) Identifier Numbers on Medicare Claims Qs & As Background Medicare may pay for items and services in clinical research studies under three policies:
More informationComprehensive Study Documents List (Biomedical Studies)
Comprehensive Study Documents List (Biomedical Studies) Investigators conducting human subjects research must maintain study documents in adherence to federal and state regulations, USC policies, and good
More informationPOLICY AND PROCEDURES OFFICE OF THE CENTER DIRECTOR. Table of Contents
POLICY AND PROCEDURES OFFICE OF THE CENTER DIRECTOR Tracking of Significant Safety issues in Marketed Drugs -- Use of the DARRTS Tracked Safety Issues Table of Contents PURPOSE...1 BACKGROUND...1 POLICY...2
More informationCMS Issues Proposal to Revise Clinical Trial Policy National Coverage Determination
Covington & Burling llp Brussels London New York San Francisco Washington Health Care E-Alert May 3, 2007 CMS Issues Proposal to Revise Clinical Trial Policy National Coverage Determination Recently, the
More informationUniversity of Hawai i Human Studies Program. Guidelines for Developing a Clinical Research Protocol
University of Hawai i Human Studies Program Guidelines for Developing a Clinical Research Protocol Following are guidelines for writing a clinical research protocol for submission to the University of
More informationPrincipal Investigator and Sub Investigator Responsibilities
Principal Investigator and Sub Investigator Responsibilities I. Purpose To define the roles and responsibilities of Principal Investigators conducting research at GRU. II. Definition The term Principal
More informationGuidance for IRBs, Clinical Investigators, and Sponsors
Guidance for IRBs, Clinical Investigators, and Sponsors IRB Continuing Review after Clinical Investigation Approval U.S. Department of Health and Human Services Food and Drug Administration Center for
More informationSaving the Details for Guidance EXAMPLE 1:
Saving the Details for Guidance EXAMPLE 1: Under Medicare EHR (electronic health records) incentive payment program, hospitals and physicians must meaningfully use EHR. The statute authorizes CMS to specify
More informationUse of Electronic Health Records in Clinical Research: Core Research Data Element Exchange Detailed Use Case April 23 rd, 2009
Use of Electronic Health Records in Clinical Research: Core Research Data Element Exchange Detailed Use Case April 23 rd, 2009 Table of Contents 1.0 Preface...4 2.0 Introduction and Scope...6 3.0 Use Case
More informationBRISTOL-MYERS SQUIBB DATA DISCLOSURE & TRANSPARENCY
BRISTOL-MYERS SQUIBB DATA DISCLOSURE & TRANSPARENCY TRUSTED COMPANY Since 2001, Sylogent systems have been utilized by leading BioPharma companies Publication Planning Data Disclosure & Transparency Study
More informationClinical Trials Management System (CTMS) Overview
Clinical Trials Management System (CTMS) Overview 8.DEC.2011 Biomedical Informatics Core (BIC) Retreat Elizabeth Micalizzi, Director, Communications and Integrated Technology, Research Affairs and VCU
More informationUnlocking the Full Value of Your Clinical Trials Management System (CTMS) Investment
Unlocking the Full Value of Your Clinical Trials Management System (CTMS) Investment May 28, 2014 YOUR MISSION OUR SOLUTIONS Huron Consulting Group Inc. All Rights Reserved. Huron is a management consulting
More informationGuidance for Clinical Investigators, Sponsors, and IRBs
Guidance for Clinical Investigators, Sponsors, and IRBs Adverse Event Reporting to IRBs Improving Human Subject Protection U.S. Department of Health and Human Services Office of the Commissioner (OC) Center
More informationNSW Cancer Trials Network Network Portfolio Policy October 2012
NSW Cancer Trials Network Network Portfolio Policy October 2012 E12/18446 Cancer Institute NSW Page 1 of 7 Contents BACKGROUND... 3 NSW CANCER TRIALS NETWORK PORTFOLIO KEY PRINCIPLES... 3 PORTFOLIO COMPLIANCE
More informationPROPOSED US MEDICARE RULING FOR USE OF DRUG CLAIMS INFORMATION FOR OUTCOMES RESEARCH, PROGRAM ANALYSIS & REPORTING AND PUBLIC FUNCTIONS
PROPOSED US MEDICARE RULING FOR USE OF DRUG CLAIMS INFORMATION FOR OUTCOMES RESEARCH, PROGRAM ANALYSIS & REPORTING AND PUBLIC FUNCTIONS The information listed below is Sections B of the proposed ruling
More informationPrepared by: Clinical Trials Monitoring Branch Cancer Therapy Evaluation Branch Division of Cancer Treatment and Diagnosis National Cancer Institute
NCI GUIDELINES FOR AUDITING CLINICAL TRIALS FOR THE NCI NATIONAL CLINICAL TRIALS NETWORK (NCTN) PROGRAM, COMMUNITY CLINICAL ONCOLOGY PROGRAM (CCOP) / NCI COMMUNITY ONCOLOGY RESEARCH PROGRAM (NCORP) AND
More informationRev. 08/2008. Rebecca and John Moores UCSD Cancer Center CLINICAL RESEARCH POLICIES AND PROCEDURES (2008)
Rev. 08/2008 Rebecca and John Moores UCSD Cancer Center CLINICAL RESEARCH POLICIES AND PROCEDURES (2008) MOORES UCSD CANCER CENTER CLINICAL RESEARCH POLICIES TABLE OF CONTENTS Page I. INTRODUCTION 4 Clinical
More informationInvestigator responsibilities for research conducted under the authority of the UTHSCSA Institutional Review Board (IRB)
March 1, 2006 M E M O R A N D U M F O R R E C O R D TO: FROM: SUBJECT: Deans Department Chairs Principal Investigators Brian Herman, Ph.D. Vice President for Research Investigator responsibilities for
More informationThe NCI CIRB Initiative: Change and Growth
The NCI CIRB Initiative: Change and Growth Jacquelyn L. Goldberg, JD Head, CIRB Initiative U.S. DEPARTMENT HEALTH AND HUMAN SERVICES NATIONAL INSTITUTE OF CTTI June 12, 2014 HEALTH The CIRB Initiative
More informationMeaningful Use - The Basics
Meaningful Use - The Basics Presented by PaperFree Florida 1 Topics Meaningful Use Stage 1 Meaningful Use Barriers: Observations from the field Help and Questions 2 What is Meaningful Use Meaningful Use
More informationPhysician Quality Reporting System (PQRS) Physician Portal
The American College of Radiology Physician Quality Reporting System (PQRS) Physician Portal User Guide January 29, 2016 American College of Radiology 1891 Preston White Drive Reston, VA 20191-4397 Copyright
More informationClinical Trials: The Crux of Cancer Innovation
Clinical Trials: The Crux of Cancer Innovation Even as medical science is transforming cancer care, major deficiencies in the way cancer clinical trials are designed, carried out, regulated and funded
More informationClinical Trials. Helpful information and answers for patients
Clinical Trials Helpful information and answers for patients I joined a clinical trial because I want to make it a better world for my daughter and grandchildren. Hopefully, by the time they re old enough
More informationSeptember 4, 2013. In reference to docket number: CMS-2013-0155-0010
September 4, 2013 Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS 1600 P Mail Stop C4 26 05 7500 Security Boulevard Baltimore, MD 21244 1850 In reference
More informationMedicaid EHR Incentive Program. Focus on Stage 2. Kim Davis-Allen, Outreach Coordinator Kim.davis@ahca.myflorida.com
Medicaid EHR Incentive Program Focus on Stage 2 Kim Davis-Allen, Outreach Coordinator Kim.davis@ahca.myflorida.com Understanding Participation Program Year Program Year January 1 st - December 31st. Year
More informationPreview of the Attestation System for the Medicare Electronic Health Record (EHR) Incentive Program
Preview of the Attestation System for the Medicare Electronic Health Record (EHR) Incentive Program The Medicare EHR Incentive Program provides incentive payments to eligible professionals, eligible hospitals
More informationNIH Research Performance Progress Reports (RPPR)
NIH Research Performance Progress Reports (RPPR) Helpful Hints for the UW Research Community This document is meant as a tool for research administrators to collect information from PIs for the new RPPR
More informationHuman Subjects Research (HSR) Series
Human Subjects Research (HSR) Series CITI Program s HSR series consists of modules from two basic tracks, Biomedical (Biomed) and Social- Behavioral- Educational (SBE), and a set of Additional Modules
More informationPolicy of the National Institute of Nursing Research for Data and Safety Monitoring of Extramural Clinical Trials
Policy of the National Institute of Nursing Research for Data and Safety Monitoring of Extramural Clinical Trials Purpose and Scope This policy sets forth the National Institute of Nursing Research (NINR)
More informationInvestigational Drugs: Investigational Drugs and Biologics
: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place
More informationApplication for Research
Application for Research All research conducted within the Brooks Rehabilitation system or any entity or facility bearing the Brooks name, including the Brooks Rehabilitation Clinical Research Center,
More informationFundamentals of Clinical Trial Financial Management
Fundamentals of Clinical Trial Financial Management Lindsey Spangler Michelle Smith COURSE OBJECTIVES Understand the life cycle of a clinical study from a financial perspective Understand the purpose of
More informationRESEARCH INVOLVING DATA AND/OR BIOLOGICAL SPECIMENS
RESEARCH INVOLVING DATA AND/OR BIOLOGICAL SPECIMENS 1. Overview IRB approval and participant informed consent are required to collect biological specimens for research purposes. Similarly, IRB approval
More information12.0 Investigator Responsibilities
v. 5.13.13 12.0 Investigator Responsibilities 12.1 Policy Investigators are ultimately responsible for the conduct of research. Research must be conducted according to the signed Investigator statement,
More informationKey considerations for outsourcing late phase clinical research
Key considerations for outsourcing late phase clinical research Alan Nelson (on behalf of Van Zyl Engelbrecht) Senior Project Director at UBC: An Express Script Company Layout of presentation My presentation
More informationGuidance for IRBs, Clinical Investigators, and Sponsors. Considerations When Transferring Clinical Investigation Oversight to Another IRB
Guidance for IRBs, Clinical Investigators, and Sponsors Considerations When Transferring Clinical Investigation Oversight to Another IRB U.S. Department of Health and Human Services Food and Drug Administration
More informationBEGINNER MEDICAID EHR INCENTIVE PROGRAM FOR ELIGIBLE PROFESSIONALS. » An Introduction to: Last Updated: April 2014
01 BEGINNER» An Introduction to: MEDICAID EHR INCENTIVE PROGRAM FOR ELIGIBLE PROFESSIONALS Last Updated: April 2014 Table of contents How to use this guide... 2 1. Program basics... 5 What is the Medicaid
More informationThe Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial
The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial Clinical Research Operations & Regulatory Support (CRORS) Ann Glasse, RN, BSN, MBA Director-CRORS Objectives
More informationMEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY
MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY On August 24, the Centers for Medicare & Medicaid Services (CMS) posted the much anticipated final rule for Stage
More informationRoles & Responsibilities of the Sponsor
Roles & Responsibilities of the Sponsor Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Funding for clinical research comes from
More informationContents: Centers for Medicare/Medicaid (CMS) Clinical Trials Policy (CTP) Training. CMS CTP Background, Definitions and Requirements
Contents: CMS CTP Background, Definitions and Requirements Process Going Forward UW Medicine Process Reminders April 2009, Slide 1 Background: In 2000, Medicare issued a National Coverage Decision (NCD)
More informationMeaningful Use Stage 1:
Whitepaper Meaningful Use Stage 1: EHR Incentive Program Information -------------------------------------------------------------- Daw Systems, Inc. UPDATED: November 2012 This document is designed to
More informationAHP Online: Guide for Project Management
AHP Online: Guide for Project Management Table of Contents Introduction...3 Section 1: How to Change a Contact Purpose/Overview...1:1 Sponsor Procedures...1:2 Sponsor Contact Changes to an Application...1:2
More informationData Management in Clinical Trials
Data Management in Clinical Trials Introduction to the Principles and Practice of Clinical Research February 19, 2013 Diane St. Germain, RN, MS Nurse Consultant Division of Cancer Prevention National Cancer
More informationThe Product Review Life Cycle A Brief Overview
Stat & Quant Mthds Pharm Reg (Spring 2, 2014) Lecture 2,Week 1 1 The review process developed over a 40 year period and has been influenced by 5 Prescription User Fee Act renewals Time frames for review
More informationFriday, May 2. Clinical Trials: Is Your Staff Competent? Session 10:15 11:45 am Ballroom C
Session 10:15 11:45 am Ballroom C Clinical Trials: Is Your Staff Competent? What fundamental skills and knowledge should clinical trials nurses have? In response to questions from its members about how
More information